Rhythm Appoints Board Members
This article was originally published in Scrip
Rhythm has appointed David Meeker, president and CEO of Sanofi's subsidiary Genzyme, and David McGirr, former chief financial officer of Cubist Pharmaceuticals, to its board of directors. Before joining Genzyme in 1994, Meeker was director of the Pulmonary Critical Care Fellowship at the Cleveland Clinic and assistant professor of medicine at Ohio State University. Previously, McGirr was senior advisor to the CEO of Cubist and from 2002 to 2013; he was senior vice president and CFO of the company. Prior to Cubist, McGirr was president and chief operating officer of internet technology company Hippo Inc., and he previously served as president and CEO of GAB Robins North America, Inc.